This review discusses promising new approaches in classical Hodgkin's lymphoma that have been recently evaluated. There is a focus on the fluorodeoxyglucose PET scanning that is now considered crucial for staging and treatment evaluation, including interim evaluation after two cycles. An up-front treatment strategy is discussed, with the place of radiation therapy and the difficult choice of chemotherapy intensity emphasized. Indications for frail patients are also reviewed, particularly elderly or HIV-positive patients. Emerging data on the antibody drug conjugate brentuximab vedotin and its future potential in the transplantation framework for relapsed/refractory Hodgkin's lymphoma is also discussed.

Download full-text PDF

Source
http://dx.doi.org/10.1586/17474086.2015.995622DOI Listing

Publication Analysis

Top Keywords

hodgkin's lymphoma
12
classical hodgkin's
8
decision-making management
4
management adult
4
adult classical
4
lymphoma determining
4
determining optimal
4
optimal treatment
4
treatment review
4
review discusses
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!